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INTRODUCTION
Every human is continuously exposed to many risks of death, such as cancer, heart disease, and tuberculosis. Because death is not a repetitive event and is usually attributed to a single cause, these risks compete with one another for the life of a person. Competing risks must be considered in any cause-specific mortality analysis. In a study of cancer as a risk of death, for example, some persons might die from other causes during the study period. These persons no longer could die from cancer, but neither would they survive to the end of the study period." What, then, would be the contribution of their survival experience to the study, and what adjustment would have to be made for the competing effect of other causes in the study of cancer? If cancer were eliminated as a risk of death, what would be a person's chance of surviving a given time period? How many years in life expectancy has one lost because cancer is risk of death? As another example, the AIDS epidemic is spreading over the world population. Does the presence the AIDS virus infection in a population increase the death rate from pneumonia, or from heart disease? Are AIDS patients more likely to die from cancer than persons without AIDS? A meaningful study of these questions requires the evaluation of AIDS as a competing risk.
The basic statistical quantities that measure the effect of a risk of death are survival probability, death probability, and life expectation. To evaluate a risk of death, we would ideally have the risk in question operate alone in a population to determine the probabilities and the expectation of life. Alternatively, we would remove the risk in question from a population and evaluate the changes in the probabilities and the life expectation. Rarely is the ideal situation realized, but one can estimate these probabilities and the expectation of life by using the theory of competing risks in a cause-specific mortality study.
In this paper, we present a brief review of the concept of competing risks and the statistical methods of mortality analysis, including estimation of three types of probability of dying with respect to a particular cause of death. We will describe formulas of estimates for cohort studies, medical follow-up studies, and analyses of mortality data for a current population. To illustrate this method of analysis, we will use the major cardiovascular (CV) diseases and malignant neoplasms mortality data of the United States white male and female population in 1986.
BACKGROUND

Evolution of the Concept of Competing Risks
The concept of competing risks began in April 1760, when Daniel Bernoulli read his memoir on mortality due to smallpox and the advantage of inoculation for its prevention before the French Academy of Science (5) . During the early eighteenth century, there were constant debates and discussions in England, France, and other European countries over the advantage of inoculation against smallpox, because deaths occurred among those who were inoculated. Data were collected and tables were prepared to show the results of some inoculation programs, without definitive conclusions regarding the advantage of inoculation, iKarn (31) gave a detailed account of the events related to this controversy.
Bernoulli had proposed a mathematical approach to the problem. He wanted to compare the mean duration of life in two differently constituted populations: a real population who were subject to death from smallpox and from other causes versus another, hypothetical population for whom smallpox was not a cause of death. Assuming that during one year one in n persons acquires smallpox, and one in rn persons who had smallpox dies, Bernoulli arrived at a formula for estimating the number of persons who will die from smallpox. He then used Edmond Halley's (27) life table of the city of Brcslou to illustrate numerically the advantage of eliminating smallpox as a cause of death. Bernoulli set n --8 and rn = 8 and calculated that inoculation against smallpox would lengthen the average duration of life by about three years.
An important assumption in Bernoulli's solution to the smallpox controversy was, in present-day terminology, a constant incidence rate (l/n) and a constant case fatality rate (l/m) for smallpox. D'Alembert, Trembley, and Laplace all had considered the problem when n and m both were functions of age. It was D'Alembert who was the most critical of Bemoulli's solution, and his criticism prompted Bernoulli to write an "Introduction apologrtique" to preface his memoir. Although he, too, recognized the value of inoculation, D'Alembert felt that Bernoulli had overstated the epidemic and overestimated the advantage of inoculation. In response to the question, "Of all persons alive at a given epoch, what fractional part has not been attacked by the small pox?" D'Alembert estimated the number at one-fourth, whereas Bernoulli estimated two-thirteenths, which gave the estimate of the smallpox "prevalence rate" at 75% ( --1-1/4) by D'Alembert and 85% ( = 1-2/13) by Bernoulli. D'Alembert also stressed the difference between the immediate danger of inoculation and the remote benefit in the additional years gained through inoculation. He also distinguished physical life from civil life, from which may have emerged the concept of quality of life. It was this exchange between D'Alembert and Bernoulli that brought out the notion of competing risks. Todhunter (49) gave mathematical details of their discussion.
Makeham (36) formulated the theory of multiple decrement forces and explored the practical applications. Actuarial mathematicians have applied Makeham's work to develop multiple decrement tables in the study of life contingencies. Spurgeon (48) described methods of analysis that invol,~ed two or more causes of decrement. In particular, Spurgeon included "withdrawal from observation" in his formula for the probability of dying during a year. The result was the now popular "actuarial method," which was promoted by Berkson & Gage (4). Bailey & Haycocks (2) di'scussed some theoretical aspects of multiple decrement life tables. Hooker & Longley-Cook (28) considered life and other contingencies. In the area of vital statistics, Greville (26) analyzed mortality tables by cause of death. The concept of competing risks also has applications in survival analysis (29, 40) , reliability theory and life testing (3) , and other fields.
Two papers on the problem of competing risks that have aroused much interest among researchers in public health were by Fix & Neyman (24) and by Cornfield (15) . Fix & Neyman introduced a stochastic model to describe recovery, relapse, death, and loss of patients in medical follow-up studies. Cornfield described problems in the estimation of the probability of the development of a disease when there were competing risks. Chiang (9) considered causes of death as competing risks and formulated relations between three types of probability of death with respect to a specific cause as a basis for mortality analysis. that has r electrical lights connected in series becomes dark as soon as one of the bulbs burns out. Each component is subject to a failure risk R i and has a potential or net lifetime Xi, for i = 1 ..... r. The lifetime of the system, denoted by Y, is the smallest of (X~ ..... Xr), or
Generally it is assumed that the r potential lifetimes, denoted by an rdimensional random vector,
has a joint distribution function
The marginal distribution of Xi,
is the net probability of failure of the i-th component before time x. Its complement, 1-Fx~ (x), is the net survival probability of the i-th component to time x. The ratio,
is the failure rate (force of mortality) of the i-th component. Thus, the connection between the potential lifetimes and competing risks is clear. Although the marginal distribution (Eq. 4) can be derived from the joint distribution (Eq. 3), the converse is not necessarily true. When the random components (X~ ..... Xr) are mutually dependent, the joint distribution (Eq. 3) cannot be derived from the marginal distribution (Eq. 4), for i = 1 ..... In David & Moeschberger (19) and in Birnbaum (6), discussion on competing risks was given in sections that dealt separately with dependent lifetimes and with independent lifetimes. Elandt-Johnson & Johnson (22) offered a review of the theory of competing risks. Using potential lifetimes, we can study competing risks within the framework of multivariate analysis (see, for example, 18, 34, 39) . Most articles have used exponential distributions (38) . Moeschberger & Klein (42) discussed consequences of departure from independence of exponential series systems. Boardman & Kendall (7) developed maximum likelihood estimators when there are only two causes of failure. Gail (25a) used the joint survival function to compare the actuarial method with other models. Birnbaum (6) devised a situation to illustrate the difference between the net and crude lifetimes of a system. In his discussion on the nonidentifiability of competing risks, Tsiatis (50) showed that, when potential lifetimes (X1 .... ,Xr) are known to be mutually independent, the crude probabilities are not of much use for identifying the joint distribution of (X~,... ,Xr) or the net distribution of each Xi. But, when risks are dependent, there is no simple statistical method available for the analysis of competing mortality risks in the human population. The competing risks problem is difficult indeed.
REMARK There is a major conceptual difficulty in using the potential lifetime theory to study competing risks in the human population. The difficulty is in the definition of sample space. Generally, the sample space of a random vector X in formula 2 is an r-dimensional space. For every sample point (x~ ..... Xr), for xi--<0, in the r-dimensional space, there is a density function f(x~ ..... xr) and a distribution function
But what does the sample point (Xl ..... x~) represent in a competing risks analysis? According to the concept of multivariate distribution, it represents the event that an individual dies from r different causes at r different times, which is an impossible event! A human being can die only once from a single cause, and no one dies more than once and at different times. Consequently, the corresponding density functionf(x~ ..... x~) has no meaning. The sample space of the random vector X = (X~ ..... Xr) is not an r-dimensional space, and neither is the domain of the distribution function Fx(x) in formula 3. It unclear what the sample space of the random vector X should be and how the distribution function Fx(x) should be determined. Perhaps we need to reevaluate some of the theoretical results regarding competing mortality risks that are derived from the distribution function Fx(x). This discussion of the conceptual difficulty also applies to the joint distribution of potential failure times in survival analysis.
In the following sections, competing risks of death will be discussed without the benefit of the potential lifetime concept. The lifetime of an individual will be represented by a single random variable that has a univariate distribution. The sample space is the positive real line, and competing risks affect the lifetime through the force of mortality.
Independence Assumption of Competing Risks
Competing risks of death are independent of one another if the force of mortality of each risk remains constant after one or more risks are eliminated www.annualreviews.org/aronline Annual Reviews or altered. Because there is no simple statistical method available for causespecific mortality analysis when risks are dependent, independence of risks is generally assumed. But some researchers have questioned the validity of the assumption (see, for example, Ref. 47) , which has become the focal point the discussion of analysis methods. Perhaps there is no unique answer to the question of risk independence. The answer probably depends on the risks involved and, possibly, on the population under study. The independence assumption may not hold among closely related causes of death, but it may be true between distant disease categories. A direct approach to the problem is to either physically remove the specific risk from the human population or introduce a new risk of death, and check the change in mortality from other causes. This seemingly drastic proposal is not always unrealistic, as we have seen in two events of the recent past. The first event occurred in 1955, when the Salk vaccine and subsequently the Sabin vaccine drastically reduced the incidence of poliomyelitis in the United States and elsewhere in the world. A thorough analysis of mortality data in the United States before and after the vaccine should help to determine the effect of poliomyelitis on other causes of death operating in the population, particularly among the very young.
The second event was the AIDS epidemic in 1981, which was a completely new risk. The epidemic started rather suddenly and spread swiftly in the human population. Tens of thousands of persons have died of AIDS and millions of others are thought to be infected with the human immunodeficiency virus. This disease and the changes in mortality also provide us with an opportunity to verify the independence assumption, at least between major disease categories. Does the appearance of AIDS affect the force of mortality of other risks of death, such as cancer?
The National Cancer Institute (NCI) has published data that may help determine if cancer is independent of AIDS. Table IV -5) . This table summarizes 14-year trends of cancer mortality from 1973 to 1986 in the United States among white males and females. For our purpose, the years 1973-1974 represent a period before the AIDS epidemic, and the years 1985-1986 represent a period after the outbreak. In addition to the age-specific cancer death rates during the before and after years, Table 1 contains percentage changes and the estimated annual percent changes from before to after for each age group among males and females. As most AIDS victims were young males and very few were females in 1985-1986, the white males may be considered "cases," and the white females, "controls." The changes in cancer mortality from before to after among males (cases) can be compared with the changes among females (controls) for each age group. If the changes in cancer mortality from before 'EAPC: Estimated Annual Percent Change over the 14-year interval. Source: Natl. Cancer Inst. May 1989. Cancer Statistics Review, Section IV, Table IV-5 to after among males are quite different from the changes among females, then cancer may be dependent on AIDS. If the changes in cancer mortality among males are similar to those among females, then cancer probably is independent of AIDS.
In the four age groups less than 55 years of age, the percentage changes in cancer death rates from before to after w6re very close: (-35.8, -18.5, -14.4, -6.9) for white males and (-33.7, -20.3, -15.6, -6.7) for white females. Thus, the NCI cancer mortality trends analysis seems to suggest that cancer is independent of AIDS. Although more data and statistical analysis are needed to establish, or to repudiate, the independence assumption, we use the assumption to proceed with our discussion.
COMPETING RISKS
Three Types of Probability
The concept of competing risks has been expressed in terms of probability of dying (9) . In a mortality analysis without specification of cause of death, the meaning of the probability of dying (in a time interval) is clear. When competing risks are considered, the probability of dying is subject to various interpretations. Each interpretation leads to a different probability, and each probability serves a different purpose. One can select a particular type of probability to suit the needs of a mortality study. To understand the concept of competing risks, one needs to understand various types of probability. For a person alive at the exact age xi, three types of probability are possible: THE CRUDE PROBABILITY: The probability of dying from a specific cause in the presence of all other competing risks. In reference to age interval (xi, xi+l), the probability is: Qi~ = Pr (of dying in the interval (xi, x~+ l) from cause R~ in the presence of all other risks the population).
THE NET PROBABILITY: The probability of dying if a specific risk is the only risk in effect in the population or, conversely, the probability of dying if a specific risk is eliminated from the population. For age interval (xi, xi+ ~), the probabilities are: qi~ = Pr (of dying in the interval (xi, xi+0 if risk R~ is the only risk in effect in the population); q~.~ = Pr (of dying in the interval (x~, X~+l) if risk R~ is eliminated as a risk of death).
THE PARTIAL CRUDE PROBABILITY: The probability of dying from a specific cause when another risk (or risks) is eliminated as a risk of death from the population. Or and pi = Pr (a person alive at age i w ill s urvive t o the e nd o f t he i nterval ( xl, xi+0), with qi 3-Pi = 1. For example, if R 1 represents the risk of dying from cancer and the age interval is (40, 45) , then the crude probability Qil is the probability that person 40 years of age will die from cancer before reaching age 45. The net probability qll is the probability of the person dying in the interval (40, 45) cancer were the only cause of death operating in a population, and qi. ~ is the probability that the person will die in interval (40, 45 ) if cancer were eliminated as a risk of death. If R2 represents the risk of death from heart disease, then the partial crude probability Qi2. i is the probability of dying in the age interval (40, 45) from heart disease, if cancer were eliminated as a risk of death.
The probabilities pi, qi, and Qi~ are real and can be estimated directly from a cause-specific mortality analysis. The net probabilities qi8 and qi.8 and the partial crude probabilities Qi&l and Qis, 12 are probabilities in a hypothetical situation. They cannot be estimated directly, but only through their relations with Pi, qi and Qi~. Generally, the net probability of dying qi.~ and the partial crude probability Ois. 1 are of particular interest in a mortality analysis, and we will use them in the following section.
The terms "risk" and "cause" need clarification, as both may refer to the same condition, but are distinguished by their position in time relative to the occurrence of death. Before death, a condition is a risk; after death the same condition is a cause. For example, cancer is risk of death to which a person is exposed, but cancer also is the cause of death if a person eventually dies from it.
Relations Between Crude, Net, and Partial Crude Probabilities
Suppose that r risks of death are acting simultaneously on each person in a population, and let these risks be denoted by R l ..... R~. For each risk, R~, there is a corresponding force of mortality p~(t;8) such that i~(t;3)dt = Pr (a person alive at time t will die in time element (t, t+dt) from risk R~), for 6 = 1, . . .,r. The sum ix(t;1) + ..
. ix (t;r) = Ix(t)
is the total force of mortality so that, www.annualreviews.org/aronline Annual Reviews CHIANG i~(t)dt = Pr (a person alive at time t will die in time element (t, t+dO).
The probability of dying qi is a function of the force of mortality /x(t):
where the limits of the integral are the limits of the interval (xi, xi+O. When the force of mortality/x(t) = /x is constant in the interval, the formula of the probability qi reduces to
where ni = xi+l-xi is the length of the interval.
PROPORTIONALITY ASSUMPTION The theory of competing risks requires two assumptions: the above-mentioned independence assumption and the proportionality assumption described below. For each risk R~, the force of mortality Ix(t;6) is a function of time t and of risk R~. Under the proportionality assumption, within the time interval (xi, xi+l) and ratio of Ix(t;6) to the total force of mortality /x(t), /x(t;6) _ ci~, 12. /.t(t) is independent of t, but is a function of the interval (xi, xi+0 and of risk R~. This assumption permits the risk-specific force of mortality tx(t;6) to vary in absolute magnitude, but requires that it remain a constant proportion of the total force of mortality in the interval (x~, x~ +0. David (17) has shown that proportionality assumption in formula 12 can be satisfied whenever the underlying distribution of lifetime has one of three possible forms of the extreme-value distribution of the minimum. Thus, the assumption also is satisfied in the exponential and Weibull distributions.
Formula 12 can be extended immediately to the probability of dying. When the ratio of the risk-specific force of mortality to the total force of mortality is constant throughout a time interval, this constant must be equal to the ratio of the corresponding probabilities of dying over the entire interval. That is, /x(t;6) _ Qi~1 3. qi www.annualreviews.org/aronline Annual Reviews and hence Qia -/x(t;6) qi, 14. /x(t) for 6 = 1 ..... r. Thus, the (crude) probability of dying in an interval from risk Ra is the proportion ix(t;6)/~(t) of the (total) probability of dying in the interval, qi. The larger this proportion is, the greater is the probability of dying from the corresponding risk R~.
Taking the summation of both sides in equation 14, for 6 = 1 ..... r, yields the equation Qil + ¯ ¯ ¯ + Qir = qi.
15.
The sum on the left hand side of the equality in formula 15 is the probability of dying from one of the risks (R~ ..... Rr), and hence is equal to the probability of dying, qi.
Using the proportionality assumption in formula 12, we find formulas that express the net probability qi.a and the partial crude probability Qia. ~ in terms of the probabilities Pi, qi and Qia. For example, when R l is eliminated as a risk of death, the net probability of dying in age interval (xi, Xi+l) 16. and the partial crude probability of dying from R~ is
17.
for 6 = 1, . . .,r. Formulas 16 and 17 are basic for estimating the net and the partial crude probabilities in practical applications of the theory of competing risks. SOME OBSERVATIONS Table 2 represents a hypothetical situation in which an individual is exposed to r = 3 risks of death (R~, R2, R3) in two time intervals. The forces of mortality of risks R~ and R3 are constant with/x(t;1) ¯ 10 and/z(t;3)= .30, respectively, in both intervals, but the force of mortality of R2 changes, from/x(t;2) = .20 in the first interval to/x(t;2)=.25 in second. These values and the total force of mortality /x(t) are recorded columns 2 through 5. The probabilities of dying q~, Qi~, qi.~, and Q~.~, computed from formulas 11, 14, 16, and 17 are shown in columns 6 through 14. The following points deserve some attention when studying competing risks of death, as illustrated with the numerical example in Table 2 . 1. A risk that has a low force of mortality has a small crude probability of www.annualreviews.org/aronline Annual Reviews dying. In Table 2 2. Elimination of a risk that has a low force of mortality will cause a small reduction in the probability of dying. Therefore, when risk R~ is eliminated as a risk of death, the net probability of dying qi.s has a reverse order of magnitude as that of the force of mortality.
In 3. When R1 is eliminated as a risk of death, the net probability of dying qi. l equals the sum of the partial crude probabilities: ql. 1 = Qi2.1 +Qi3.1, because when R~ is eliminated, an individual either dies from R2 with a probability ai2.1 or dies from R 3 with a probability Qi3.1. Therefore their sum equals qi. 1.
From columns 10, 13 and 14, we find the equality .393 =. 157+ .236 in the first interval and the equality .424 = .193+.231 in the second.
4. Although survival and death of an individual are determined by the force of mortality Ix(t), the chance of dying from a specific cause is influenced competing risks. For example, the crude probability of dying from risk R~, Qil, is a function of the force of mortality/x(t;l), as well as the forces mortality of R2 and R3, Ix(t;2) and/x(t;3). The probability Qil decreases as sum /~(t;2) + Ix(t;3) increases, even when Ix(t;l) remains unchanged.
In Table 2 , the crude probability of dying from R~ decreases from Qil = .075 in the first interval to Qi~ ~ .073 in the second when /~(t,'2) increases from Ix(t,'2) --.20 to Ix(t;2) = .25, even though /~(t;1) --.10 in intervals.
5. Independence of competing risks is judged by the force of mortality, not by the (crude) probability of dying. In this example, risk RI is independent risk R2, because the force of mortality of R l Ix(t,l) remains constant when /x(t;2) changes in the two intervals; however, the crude probability of dying from RI, Qil, changes with Ix(t;2). Similarly, risk R 3 also is independent of risk R2. as/~(t;3) = .30 in both intervals, although Qi3 changes with Ix(t;2).
6. When R~ is eliminated, only Re and R 3 remain as competing risks. The (partial crude) probability of dying from R 3 is affected by the magnitude of the force of mortality of R2 /z(t;2).
When /x(t;2) increases from .20 to .25, the probability of dying from www.annualreviews.org/aronline Annual Reviews decreases from Qi3.1 = .236 in the first interval to Qi3. i = .231 in the second. The example in Table 2 was taken, with changes, from a table in Kimball (32). Kimball suggested a conditional probability of dying from a risk, say R2, given not dying from another risk, Rl, or Qi2/(1-Qil), as a substitute for the partial crude probability Qi2.1. These two probabilities, however, are different in concept. Kimball's article has caused much discussion from Mantel & Bailer (37), Pike (46) , and Chiang (13) . Another substitute for partial crude probability Qi2.1 was proposed by Wong (51) , who uses multiple causes of death information to estimate the additional number of deaths from R 2 if risk R1 is eliminated as a risk of death.
Estimation of Probabilities
Chiang (9, 12) and David & Moeschberger (19) have reported methods analysis and statistical inference in competing risks studies. This section briefly describes probability estimates in three types of studies: cohort, medical follow-up, and current population mortality analysis.
COHORT STUDIES Let a cohort of lo newborn infants be observed from birth until the death of the last member of the cohort. For age interval (xi, xi+ 1), let I i be the number of persons (out of 10) alive at xi, li+ 1 who survive to age xi+ and di~ die from cause R~, for 6 = 1 ..... r, so that dil + ¯ ¯ ¯ + dir q-/i+l = li ¯18.
Each of the li individuals is subject to the probability Qi8 of dying from R8 in (xi, Xi+l) and Pi of surviving to xi+l, with Qil + . . . + Qir + pi = 1.
19.
Estimates of the probabilities in formula 19 are the corresponding proportions in formula 18. Namely, Oi~ = di6lli, ~li : di/li, and Pi = li+l/li, 20.
for 6 = 1 ..... r; where di = di~ + ... +dir is the total number of deaths in the interval (xi, Substituting the estimates 0i~, ~i and/0 i in formulas 16 and 17 yields the estimates of the net and the partial crude probabilities:
and www.annualreviews.org/aronline Annual Reviews
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Birnbaum (6) proved that, under the proportionality assumption 12, Oi.~ formula 21 is a consistent estimate of the probability qi.6-Using Bimbaum's approach, we can show that Oi~. 1 in formula 22 is a consistent estimate of the probability Qi~.l.
MEDICAL FOLLOW-UP STUDIES Consider a medical follow-up study conducted over a period of y years. A total of No patients are admitted to the study at various times during the study period and observed until either their deaths or the end of the observation period (such as termination of the study), whichever comes first The typical interval will be denoted by (x, x+l), for x = 0, 1 .... ,y-l, so that x is the exact number of years of follow-up. The symbol Px will denote the probability that a patient alive at time x will survive to the end of the interval (x, x+ 1); qx, the probability of dying during the interval; and Qx~, the probability of dying during the interval from cause R~, with Qxl + ¯ ¯ ¯ + Qxr = qx, and Px + qx = 1. At time x, there are N~ patients alive and to be observed over the interval (x, x+ 1). Of these patients, Sx will survive to time x+ 1 to become Nx+ 1; Dx~ will die from R~ in (x, x + 1), for 6 = 1 ..... r. Finally, the sum Dxl + ¯ ¯. +Dxr = Dx is the total number of deaths in (x, x+ 1).
Up to this point, the follow-up study is similar to the cohort study. In a follow-up study, however, there are two categories of patients for whom the survival and mortality information will be incomplete. First, there will be patients who are admitted to the study between x and x+ 1 years before termination of study. These patients cannot be observed for the entire interval (x, x+ 1). They are subject to withdrawal from the study during the interval. Second, there will be patients who are lost to the study because of follow-up failure in the interval (x, x+l). Survival or death of these patients will unknown to the researchers. These two groups of patients are different from a statistical viewpoint, simply because every one of the N~ patients is subject to the risk of getting lost, but only those who are admitted between x and x+ 1 years before termination of study are subject to withdrawal in (x, x+ 1). Loss to follow-up can be treated as a competing risk, whereas withdrawal should not be. However, when the end of observation of each patient is known, the distinction between the two groups has little effect on the estimates of the probabilities.
The two sources of incomplete information have created interesting statistical problems. Many have contributed to the method of analysis of follow-up data. Spurgeon (48) With the current easy access to computer facilities, one should collect more information so that statistical formulas will be simple in concept and require fewer assumptions. The most useful information in a follow-up study is the time of each death, the time of every withdrawal, and the time when a patient is lost for each lost case. With such information in mind, we can proceed to derive estimates of the probabilities Px, Qxl ..... Qxr. For convenience, being lost is considered as a competing risk denoted by Ro with the "force" tx(t;O). The estimates ofpx , qx, and Qx6 arc function of the number of deaths and the total length of observation Tx (12) . Namely,
and ~x = 1-/~x. Using formulas 16 and 17 once again, we can find the estimates of the net and the partial crude probabilities. For example, the estimate of the net probability q.~.a is
CURRENT POPULATION MORTALITY ANALYSES Mortality data of a current population, such as the United States 1989 population, are of the form of age-specific and age-cause-specific death rates. The National Center for Health Statistics publishes annual vital statistics that contains tables of agespecific death rate Mi and age-cause-specific death rate Mi~, for each cause Rã nd for each interval (xi, xi+ 0, by race and sex for the US population and for many geographical areas in the country. The rates also can be computed from Mi = Oi/Pi and Mi~ = Digi/Pi, for 6 = l,...,r, and i = 0,1,...,w. Here, Di6 is the number of deaths from cause R~, Di = Dil+ ¯ ¯ ¯ + Dir is the total number of deaths, and Pi is the midyear population for age interval (xi, xi+ ~) during the current year. The midyear population Pi can be found in the Bureau of the Census publications (8) . Tables 3 and 4 show age-specific death rates for all causes (Mi), for malignant neoplasms (ICD# 140-209) (Mi0 and for major cardiovascular diseases (ICD# 390-448) (M~2), for white males and white females in United States in 1986. The last age interval is an open interval, Xw and above. In this case, Xw = 85 years.
These rates are used to derive estimates of the probabilities qi and Qi,s by means of formulas of conversion. Several conversion formulas from death rate Mi to the probability q~ (known as methods of life table construction) have appeared during the development of the life table. King (32a) used a graduation process to derive qi from Mi. Reed & Merrell (47a) proposed an exponential function of Mi for 1-qi. Greville (25b) used Euler-Maclaurin summation formula to obtain a formula for qi. The formulas proposed by Chiang (11), Sirken (47b) , and Keyfitz (31a) all use the concept fraction of the last age interval of life a~. When a person dies in an age interval (xi, x~+0, he or she has lived a fraction of the interval before death. This fraction varies from one person to another; the mean (expected) value is the fraction a~. Generally, the fraction ai is invariant with respect to cause of death and is subject to little variation over time. For a discussion of the fraction see Chiang (12, p. 204 ). The average length of time lived in the interval (x~, x~+ by those who die during the interval is aini, where ni = Xi+l--Xi is the length of the interval. We discuss one of the formulas below.
This formula of converting the age-specific death rate M i tO the corresponding age-specific probability of dying qi is based on the following definition of the death rate M~: For a person alive at age xi, the number of deaths is either one or zero.  If the person dies in the interval (with a probability qi), the number of deaths  is one. If the person survives the interval (with a probability 1-qi) , the number of deaths is zero. Therefore, the expected number of deaths is qi, which is the numerator in formula 26. For the denominator, we realize that the person is exposed to the risk of dying in the entire interval (xi, xi+ ~). But this exposure to death ends as soon as death occurs. If the person dies in the interval (with www.annualreviews.org/aronline Annual Reviews which was given in Chiang (11) . For a theoretical derivation see Chiang (14) and Elandt-Johnson & Johnson (22) . The age-cause-specific death rate Mi~ from cause R~ is defined in a similar manner as Mi. For a person alive at age xi, the death rate Mi~ is defined as: Mi~ = expected number of deaths from cause R~ in (xi, xi+ ~) 29. expected length of exposure to the risk of dying from cause R~ in (xi, xi+~)
The corresponding analytic formula is
The probability Qi~ in the numerator is the expected number of deaths from Rĩ n (xi, xi+l). The denominator is the expected length of exposure to the risk dying from R~, which of course is the same as the denominator in formula 27. Equations 27 and 30 imply that the estimate of Qia is given by Mia 0,8 = ~ ~i.
31.
Note that formula 31 is a logical extension of formula 14, as the ratio of two death rates is equal to the ratio of the corresponding forces of mortality. In summary, formulas 28 and 31 are used to estimate the probabilities qi and Qis, for each age interval. Substituting these formulas in 16 and 17 gives formulas for estimating the net probability q~.~ and the partial crude probability Qia.1. For example, estimate of qi.~ is
where/5i = 1 -Oi.
An Application to Current Mortality Analysis
We have chosen the net probability of dying (q~.8) as an example, and use the current mortality data from malignant neoplasms (ICD # 140-209) and major CV diseases (ICD# 390-448) of US white male and female populations 1986 for illustration. Cardiovascular diseases and malignant neoplasms have been the major causes of death in the US for many years. These diseases accounted for nearly 70% of all deaths in the entire white population in 1986, including 75% of deaths among persons aged 55 or older. Cardiovascular diseases alone were responsible for 50% of all deaths among persons older than age 75. Tables 5, 6 , and 7 show the impact of these diseases on the probability of dying and the expectation of life in numerical figures.
www.annualreviews.org/aronline Annual Reviews (1) (2) (3) (4) (5) (6) (7) (8) In Table 5 , typical multiple decrement tables show the relative importance of different risks of death and changes in the importance as age advances. In the present case, three risks are included: malignant neoplasms (RI), major CV diseases (R2), and other causes (R3). The sum of the crude probabilities equals the probability of dying: Qil+Qi2+Qi3 --qi, for each age interval (Xi, Xi+l). Under age 50, mortality level was low, with neither neoplasms nor CV diseases playing an important role in the probability of dying. From age 50 on, both CV diseases and neoplasms began to assert their influence. For white males, CV disease definitely was the greater risk of death. In age interval (50, 55) , the probability of dying from CV diseases was about 40% the probability of dying from all causes (Qi2/qi =.40). This proportion increased steadily with age: from 45% for age interval (60, 65), to 50% for age interval (75, 80), and 53% for age interval (80, 85). Thus, from age 75 on, about one in every two white male deaths was attributable to CV diseases.
The absolute value of the probability of dying from CV diseases also increased with age. For white males, the probability was Qie = 150 per 10,000 for age interval (50, 55) , to Qi2 = 2243 per 10,000 for age interval (80, 85)--a 1400% increase: over 35 years of life, or 40% per year! Malignant neoplasms are the second most important risk of death. During 1986, for white males, the probability of dying from malignant neoplasms also increased with age: from Qi! = 105 per 10,000 for age interval (50, 55) Qil --835 per 10,000 for age interval (80, 85), which is nearly a 700% increase over the 35 years. For white males, the risk of dying from neoplasms was about 70% as high as major CV diseases in the age interval 50-65 years. Beyond age 65, the relative importance of neoplasms decreases with age, because CV diseases became the dominant risk of death.
The mortality pattern among white females differs from that among white males. Table 5 confirms the general impression that females live longer. Between ages 45 and 75, the sex ratio of the probability of dying, qi(f):q~(m), was consistently lower than 60%. Also, CV discascs were not as overwhelming a risk of death among white females as among white males. Below age 65, the probability of dying from CV diseases was lower than that from neoplasms. Beyond age 65, CV diseases overtook neoplasms and assumed the role of the major risk of death among white females. IMPACT OF CARDIOVASCULAR DISEASES ON HUMAN MORTALITY AND HUMAN LONGEVITY Major cardiovascular diseases, as illustrated in Tables  5-7 , have caused more deaths in the human population than has any other diseases. To evaluate the impact of the CV diseases on human longevity, we can compare the mortality and survival experience of the current population with the hypothetical experience of the same population under the conditions that would exist if major CV diseases were removed as a risk of death. The basic quantities needed for this purpose are the probability qi and the net probability qii2 that a person alive at age xi will die in age interval (xi, xi+ ~) CV diseases (Re) were eliminated as a risk of death. The required data are age-specific death rate M i and age-cause-specific death rate Mi2 for each age interval (xi, xi+ I), given in Table 3 for white males and in Table 4 for white females. Using a procedure described in Chiang (12) , two life tables had been constructed for each group: one based on the probability q~ using formula. 28, and other based on the net probability qi.2 computed from formula 32,. The probabilities and the corresponding expectations of life shown in Tables 6 and 7 reflect in different ways the effect of the CV diseases on human mortality. Table 6 gives a comparison between the probabilities q~ and q~.2. The www.annualreviews.org/aronline Annual Reviews difference qi-qi.2 is the reduction in probability of dying if CV diseases were eliminated, or alternatively, the excess probability of dying because of the presence of CV diseases. The difference was not pronounced before age 40 because the disease then is quite rare, but advances with age at an accelerated rate. If CV diseases were removed, the reduction in the probability of dying in age interval (40, 45) would be 28.8% for white males and 18% for white females. For age interval (50, 55) , the reduction in the probability of dying would be over 40% for white males and nearly 25% for white females. At age 70 or older, the reduction would be about 45% for both white males and females. The impact of the major CV diseases on the expectation of life are shown in Table 7 , where e i is the "real" expectation of life in the current population under the normal condition with the presence of all causes of death, whereas ei.2 is the (hypothetical) expectation of life if CV diseases were eliminated as cause of death. The difference ei.2-ei is the increase in the life expectancy if CV diseases were eliminated, or the number of years lost because the presence of CV diseases as a risk of death. The nearly constant difference ei.2-e i under age 50 was because CV diseases cause death mainly among older persons and the reduction in the expectation of life because of CV diseases occurred almost entirely in persons older than age 50.
As the CV diseases became an increasingly dominant cause of death in older ages, the expectations of life el.2 became much greater than the expectation e i. At age 60, the expectation of life for white males was ei.2=26.2 years and e~ = 18.2 years, with a difference of ei.2-ei = 8 years, a 43% reduction because of the presence of CV diseases. The corresponding reduction for white females was 54.7%. At age 70, the expectations were ei.2---19.2 and ei = 11.7 for white males with a relative reduction of 62%, and ei. 2 = 28 and e i = 15.3 for white females with a relative reduction of 82.6%. Thus, if the major CV diseases were eliminated as a cause of death, a white male could expect an additional 8 years of life at age 60, and nearly 71/2 additional years of life at age 70. For white females, the increase in the life expectancy would be even more impressive. If CV diseases were eliminated, a white female could enjoy an additional 12V2 years of life at age 60 and at age 70. www.annualreviews.org/aronline Annual Reviews
